Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterization of attenuated coxsackievirus B3 strains and prospects of their application as live-attenuated vaccines.

Expert opinion on biological therapy - 1 Feb 2010

Kim Dae-Sun, Nam Jae-Hwan

Abstract excerpt

Coxsackievirus strain CVB3 is widespread in the human population and causes myocarditis or pancreatitis. However, despite its clinical impact, there is no commercially available and clinically applicable prophylactic vaccine. This study examines the characteristics of attenuated CVB3 strains developed so far and their application as live-attenuated CVB3 vaccines, and discusses problems to be overcome in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Viral
Share to Coxsackievirus Infections
Share to Enterovirus

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Vectors

Share to Mutation

Share to Receptors, Virus

Share to Vaccines, Attenuated

Source

Identifiers

PMID: 20088713
DOI: 10.1517/14712590903379502

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterization of attenuated coxsackievirus B3 strains and prospects of their application as live-attenuated vaccines.PMID 20088713Read ↗

Neutralizing activity induced by the attenuated coxsackievirus B3 Sabin3-like strain against CVB3 infection.Semantic proximity Read ↗

Attenuation of coxsackievirus B3 by VP2 mutation and its application as a vaccine against virus-induced myocarditis and pancreatitis.Semantic proximity Read ↗

Attenuated strain of CVB3 with a mutation in the CAR-interacting region protects against both myocarditis and pancreatitis.Semantic proximity Read ↗

A genetically engineered attenuated coxsackievirus B3 strain protects mice against lethal infection.Semantic proximity Read ↗

Whole-genome analysis of coxsackievirus B3 reflects its genetic diversity in China and worldwide.Semantic proximity Read ↗

Whole-Genome Analysis of Coxsackievirus B3 Reflects Its Genetic Diversity in China and WorldwideSemantic proximity Read ↗

A Self-Assembled Viral Protein VP1 Induces Protective Immunity Against Coxsackievirus B3 (CVB3) Lethal Challenges in Balb/c Mice ModelSemantic proximity Read ↗

Characterization of an infectious cDNA copy of the genome of a naturally occurring, avirulent coxsackievirus B3 clinical isolate.Semantic proximity Read ↗

Screening of a potential coxsackievirus B4 vaccine strain through analysis of biological featuresSemantic proximity Read ↗

Isolation and characterization of a highly evolved type 3 vaccine-derived poliovirus in China.Semantic proximity Read ↗

Expression of immunoregulatory cytokines by recombinant coxsackievirus B3 variants confers protection against virus-caused myocarditis.Semantic proximity Read ↗

Molecular epidemiology of Coxsackievirus B3.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.